The New Age of Personalized Medicine

The New Age of Personalised Medicine

Medicine is undergoing its most profound transformation since the discovery of antibiotics. The new age of personalised medicine — also called precision medicine — moves away from the “one-size-fits-all” approach and toward treatments and prevention strategies tailored to each individual’s unique genetic makeup, lifestyle, and environment.

What Is Personalised Medicine?

Personalised medicine uses information about a person’s genes, proteins, and environment to prevent, diagnose, and treat disease more precisely and effectively. Rather than prescribing the same drug at the same dose to every patient with the same diagnosis, personalised medicine asks: What is the right treatment for this specific patient, based on their unique biology?

Key Pillars of Personalised Medicine

• Genomics — understanding how genetic variants influence disease risk, drug response, and health outcomes

• Pharmacogenomics — using genetic information to guide drug selection and dosing, reducing adverse drug reactions and improving efficacy

• Biomarker-driven diagnosis — using molecular biomarkers to classify disease subtypes and select targeted therapies (especially in oncology)

• Preventive genomics — identifying genetic predispositions to disease before symptoms appear, enabling targeted prevention

• Digital health integration — combining genomic data with wearable health data, electronic health records, and AI-driven analytics for holistic health insights

Personalised Medicine in India

India faces a unique challenge: a vast, genetically diverse population with a high burden of both communicable and non-communicable diseases, and a healthcare system that is still largely reactive rather than preventive. MapmyGenome has been at the forefront of bringing personalised genomic medicine to India since 2013 — making DNA-based health insights accessible, affordable, and actionable for every Indian.